Skip to main content
. 2014 Apr 18;14:272. doi: 10.1186/1471-2407-14-272

Table 4.

Standardised incidence ratios of second primary cancers at >60 days - 5 years

 
Registry
IARC/IACR rules
SEER rules
Registry‡
First primary cancer Number with second cancer SIR (95% CI) Number with second cancer SIR (95% CI) Number with second cancer SIR (95% CI) Number with second cancer SIR‡ (95% CI)
Lung (C33-34)
119
0.79
(0.65, 0.94)
105
0.69
(0.57, 0.84)
112
0.74
(0.61, 0.89)
98
0.83
(0.67, 1.01)
Colorectal (C18-20)
324
0.89
(0.80, 1.00)
301
0.83
(0.74, 0.93)
323
0.89
(0.80, 1.00)
271
0.86
(0.76, 0.97)
Female breast (C50)
363
0.96
(0.86, 1.06)
272
0.71
(0.63, 0.80)
348
0.92
(0.82, 1.02)
274
0.96
(0.85, 1.08)
 Age <50
52
2.13
(1.58, 2.78)
25
1.02
(0.65, 1.50)
49
2.00
(1.48, 2.64)
28
1.67
(1.11, 2.42)
 Age ≥50
311
0.88
(0.78, 0.98)
247
0.69
(0.61, 0.78)
299
0.84
(0.75, 0.94)
246
0.92
(0.81, 1.04)
Prostate (C61)
342
0.71
(0.63, 0.79)
339
0.70
(0.63, 0.78)
323
0.89
(0.80, 1.00)
339
0.88
(0.79, 0.98)
Head & neck (C00-C14, C30-C32)
204
1.93
(1.67, 2.21)
196
1.85
(1.60, 2.13)
201
1.90
(1.64, 2.18)
176
1.74
(1.49, 2.02)
Stomach (C16)
46
1.05
(0.77, 1.40)
43
0.98
(0.71, 1.32)
44
1.00
(0.73, 1.35)
43
1.02
(0.74, 1.38)
Bladder (C67)
140
1.41
(1.19, 1.67)
138
1.39
(1.10, 1.55)
140
1.41
(1.19, 1.67)
139
1.46
(1.23, 1.73)
Oesophagus (C15)
26
0.80
(0.52, 1.17)
25
0.77
(0.50, 1.13)
25
0.77
(0.50, 1.13)
25
0.80
(0.51, 1.18)
Melanoma (C43)
102
1.35
(1.10, 1.64)
75
0.98
(0.77, 1.23)
102
1.35
(1.10, 1.64)
75
1.01
(0.79, 1.27)
Ovarian (C56)
19
0.61
(0.36, 0.95)
18
0.58
(0.34, 0.91)
19
0.61
(0.37, 0.95)
18
0.60
(0.36, 0.95)
All of above 1685 0.96 (0.91, 1.00) 1512 0.86 (0.81, 0.90) 1637 1.00 (0.95, 1.05) 1458 0.99 (0.94, 1.04)

‡excluding same site.

Abbreviations:SEER Surveillance Epidemiology and End Results, IARC International Agency for Research on Cancer, IACR International Association of Cancer Registries, SIR standardised incidence ratio, CI confidence interval.